Basilea To Divest Chinese R&D Subsidiary To PHT International In $6.3 Mln Deal

(RTTNews) – Basilea Pharmaceutica Ltd. (BPMUF.PK) announced Monday that it has entered into an agreement to divest its Chinese research and development or R&D subsidiary Basilea Pharmaceutica China Ltd. or BPC.Under the deal, the company will sell BPC’s parent company BPh InvRead MoreMarketsMarkets Feed

¡Haz clic para votar esta entrada!
(Votos: 0 Promedio: 0)

Deja un comentario